Related Experiment Video
Updated: Jun 16, 2026
07:36
Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice
Published on: September 26, 2018
Nitro-fatty acids reduce atherosclerosis in apolipoprotein E-deficient mice
Tanja K Rudolph1, Volker Rudolph, Martin M Edreira
1Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA, USA. t.rudolph@uke.de
Arteriosclerosis, Thrombosis, and Vascular Biology
|February 20, 2010
Summary
Electrophilic nitro-fatty acids, like nitro-oleic acid, effectively reduce atherosclerosis progression in mice by inhibiting inflammation and foam cell formation. These compounds offer a promising therapeutic strategy for cardiovascular disease.
Area of Science:
- Cardiovascular Science
- Inflammation Research
- Metabolic Disease
Background:
- Atherosclerosis involves inflammation and foam cell formation.
- Electrophilic nitro-fatty acids possess anti-inflammatory properties.
- In vivo effects of nitro-fatty acids on atherosclerosis are not well understood.
Purpose of the Study:
- To investigate the in vivo antiatherogenic effects of electrophilic nitro-fatty acids.
- To elucidate the mechanisms by which nitro-fatty acids impact atherosclerotic lesion development.
Main Methods:
- Administration of 9- and 10-nitro-octadecenoic acid (nitro-oleic acid) to apolipoprotein E-deficient mice.
- Analysis of atherosclerotic lesion formation, serum lipoproteins, and inflammatory markers.
- Assessment of foam cell formation and plaque stability indicators.
Main Results:
- Nitro-oleic acid significantly reduced atherosclerotic lesion formation without altering serum lipoproteins.
- Treatment suppressed tissue oxidant generation, adhesion molecule expression, and inflammatory cell infiltration.
- Nitro-oleic acid attenuated foam cell formation and increased collagen and alpha-smooth muscle actin content in lesions.
Conclusions:
- Electrophilic nitro-fatty acids demonstrate potent antiatherogenic actions in a murine model.
- Nitro-fatty acids represent a potential therapeutic avenue for atherosclerosis.
More Related Videos
Related Concept Videos
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:38Inflammation
Overview
01:30Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...